This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Universitario HM Sanchinarro, Madrid

University of Miami, Miami

Florida Cancer Specialists, Sarasota

Tennessee Oncology, PLLC, Nashville

Hospital Politècnic La Fe, Valencia

Froedtert and The Medical College of Wisconsin, Milwaukee

Stephenson Cancer Center, Oklahoma City

John Theurer Cancer Center, Hackensack

Cross Cancer Institute (University of Alberta), Edmonton

Princess Margaret Cancer Centre, Toronto

BioVirtus Research Site Sp. z o.o., Józefów

Onco.Cent. - Instit. of Maria Sklodowskiej-Curie, Warsaw

Hospital Universitari Dexeus, Barcelona

Sarah Cannon Research Institute, London